A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.

نویسندگان

  • Krasimira Aleksandrova
  • Shu-Chun Chuang
  • Heiner Boeing
  • Hui Zuo
  • Grethe S Tell
  • Tobias Pischon
  • Mazda Jenab
  • Bas Bueno-de-Mesquita
  • Stein Emil Vollset
  • Øivind Midttun
  • Per Magne Ueland
  • Veronika Fedirko
  • Mattias Johansson
  • Elisabete Weiderpass
  • Gianluca Severi
  • Antoine Racine
  • Marie-Christine Boutron-Ruault
  • Rudolf Kaaks
  • Tilman Kühn
  • Anne Tjønneland
  • Kim Overvad
  • J Ramón Quirós
  • Paula Jakszyn
  • María-José Sánchez
  • Miren Dorronsoro
  • Maria-Dolores Chirlaque
  • Eva Ardanaz
  • Kay-Tee Khaw
  • Nicholas J Wareham
  • Ruth C Travis
  • Antonia Trichopoulou
  • Pagona Lagiou
  • Dimitrios Trichopoulos
  • Domenico Palli
  • Sabina Sieri
  • Rosario Tumino
  • Salvatore Panico
  • Anne M May
  • Richard Palmqvist
  • Ingrid Ljuslinder
  • So Yeon J Kong
  • Heinz Freisling
  • Marc J Gunter
  • Yunxia Lu
  • Amanda J Cross
  • Elio Riboli
  • Paolo Vineis
چکیده

BACKGROUND Neopterin may be relevant for colorectal cancer (CRC) development, as a biomarker of cellular immune activity exerting pleiotropic effects on cellular ageing, oxidative stress, and inflammation. So far, the association between prediagnostic neopterin and colon and rectal cancer risk has not been evaluated in human populations. METHODS A nested case-control study was conducted within the European Prospective Investigation into Cancer and Nutrition cohort using data on plasma concentrations of total neopterin (T-N, sum of neopterin and 7,8-dihydroneopterin) in 830 incident CRC case patients (561 colon and 269 rectal) matched within risk sets to 830 control participants. A subsequent replication study used data from the Hordaland Health Study, where 173 CRC case patients have been diagnosed among 6594 healthy participants over 12 years of follow-up. RESULTS After multivariable adjustment for a priori chosen CRC risk factors, a "U-shaped" association of T-N with CRC was revealed. Compared with the second quintile of the T-N distribution, the relative risks for the first, third, fourth, and fifth quintiles were 2.37 (95% CI = 1.66 to 3.39), 1.24 (95% CI = 0.87 to 1.77), 1.55 (95% CI = 1.08 to 2.22), and 2.31 (95% CI = 1.63 to 3.27), respectively. Replication of these associations within the Hordaland Health Study yielded similar results. No differences have been observed when the associations were explored by colon and rectal cancer site (two-sided P difference = .87) and after excluding case patients diagnosed within the first four follow-up years. CONCLUSIONS These novel findings provide evidence of the role of both suppressed and activated cell-mediated immunity as reflected by prediagnostic T-N concentrations in the development of CRC.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Re: Personality and the risk of cancer.

Nakaya et al. (1) presented a large prospective study demonstrating that personality does not play a substantial role in the causation of cancer. As the authors concluded, the association between neuroticism and prevalent cancer may be a consequence, rather than a cause, of cancer diagnosis or symptoms. This result obviously contrasts with those of other studies [e.g., (2)] showing that chronic...

متن کامل

Does ethnicity affect survival following colorectal cancer? A prospective, cohort study using Iranian cancer registry

  Background:The present study compared the differences between survivals of patients with colorectal cancer according to their ethnicity adjusted for other predictors of survival.   Methods: In this prospective cohort study patients were followed up from definite diagnosis of colorectal cancer to death. Totally, 2431 person-year follow-ups were undertaken for 1127 colorectal cancer patients on...

متن کامل

ارزیابی فراوانی جهش‌های ژن KRAS در بیماران ایرانی مبتلا به سرطان کولورکتال

Background: Kirsten rat sarcoma (KRAS) gene is a target of genetic alterations which are diagnostic and prognostic biomarkers in patients with metastatic colorectal cancer who are treated with monoclonal anti-EGFR antibodies such as cetuximab and panitumumab. KRAS mutations are seen in 35-42% of patients with colorectal cancer. The high frequency of these mutations in colorectal cancer represen...

متن کامل

Expression Changes of the FOXE1 and lncRNA PTCSC2 Expression in Tumor Tissues Compared with Normal Tissues in Patients with Colorectal Cancer

Introduction: In recent studies, methylation of FOXE1 in colorectal cancer has been reported as a diagnostic biomarker. In this study for the first time, the expression of FOXE1 and PTCSC2 in colorectal cancer was investigated and their expression patterns in two healthy and tumor tissues of patients were compared. Methods: In this study, 40 tumor tissues with colorectal cancer and 40 adjacent...

متن کامل

Spatial Analysis of Factors Affecting Colorectal Cancer Using the Model of Geographical Weight Regression in Iran

Background and Objectives: The incidence of colorectal cancer has increased significantly in Iran in recent decades. The pattern of occurrence varies in different populations. A study was conducted to perform a spatial analysis of colorectal cancer and some of its risk factors in Iran using GIS.   Methods: The data of this descriptive-analytic study included colorectal cancer incidence as a d...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of the National Cancer Institute

دوره 107 4  شماره 

صفحات  -

تاریخ انتشار 2015